Company news
XtalPi Holdings Limited news in 2026
XtalPi Holdings Limited's news releases, calls and decks from 2026, newest first.
Voluntary announcement increase in shareholding in the company by the chairman of the board
October 7, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 6, 2026
Next Day Disclosure Return
October 5, 2026
XtalPi Advances Hair Loss Drug Program into IND-Enabling Studies
October 2, 2026
XtalPi and Fangda Carbon Deploy Predictive AI to Optimize Cost and Material Efficiency in Graphite Electrode Manufacturing
October 2, 2026
Next Day Disclosure Return
October 2, 2026
XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain
September 24, 2026
Grant of share options and restricted share units
September 23, 2026
XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
September 22, 2026
Voluntary announcement plan to increase shareholding in the company by the chairman of the board
September 20, 2026
Voluntary announcement strategic drug discovery collaboration between xtalpi subsidiary LCC technologies and stanford university
September 17, 2026
XtalPi Holdings Limited to Announce 2026 Interim Results on August 19, 2026
August 12, 2026
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
June 10, 2026
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
May 29, 2026
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
May 3, 2026
XtalPi Holdings Announces Full Year 2025 Annual Results
March 25, 2026
XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026
March 13, 2026
XtalPi's AI + Robotics Platform Powers First Clinical Milestone for ReviR's Rare Neurological Drug RTX-117
March 2, 2026
Leading Automation Capabilities of XtalPi Recognized by Global Chemical Giant - Successful Launch of Advanced Automated Workstation at BASF
February 9, 2026
XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision
January 29, 2026
Decks in 2026
- H1 2026 Earnings Presentation
Earnings · 38 slides · August 2026